Crescendo Biologics to collaborate with world-leading oncology groups at the University of Oxford and the University of Surrey

Crescendo Biologics to collaborate with world-leading oncology groups at the University of Oxford and the University of Surrey

View PDF

Crescendo Biologics strengthens leadership team with appointment of ex-GSK Stewart Kay, as Chief Business Officer

Crescendo Biologics strengthens leadership team with appointment of ex-GSK Stewart Kay, as Chief Business Officer

View PDF 

Crescendo Biologics to present preclinical data on its lead Humabody® candidate, CB307, at the Cell Engager Therapeutics Summit 2019

Crescendo Biologics to present preclinical data on its lead Humabody® candidate, CB307, at the Cell Engager Therapeutics Summit 2019

View PDF